Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Down $0.05 - so sad - now its going to take 10 years to get back to $26
My issue with the Canadian system and others is its often the US consumer that pays for most of this research and then places like Canada and the rest of the world pick it up for pennies on the dollar.
Does anyone find it very odd that the UNiformed Fire Officers Family Protection PLan in interested in spending significant cash on lawyers fees to join the Dr. Reddys lawsuit when their cost of vascepa might be under $10,000 per year -- LIzzy might do some investigative research ...
If he wants to save money then he should get rid of the top heavy management, all the execs perks, free stock etc etc oh yes but NOT the SHEROES !!!
Up another 3 cents !!! Yee haw only 4 more years of this and it could hit $26
but if we put inflation in It may be 5 !!
SOmeone needs to ask if they are working on any new condos in Switzerland ...
Like I said ... its MAGIC !!!
It works for smoking as well !!! Amazing ! Heart disease Covid smoking prostate cancer Alzheimer's ...its like MAGIC !!!
Lovaas scripts increasing significantly . Maybe prescribers dont understand the difference in types of fish oil . Hey I have an idea lets write some articles to explain this. NA don't worry Eunucha's marketing arm has this all under control
Its up 3 cents !!! yee haw !! If it does this very day for another 4 years it will be back to $26!!
Which is why if Eunucha ( formerly AMRN ) was on the ball they would have run a statin intolerant branch in REDUCE IT
Market beat analysis from 2 weeks ago
A number of brokerages have recently issued reports on AMRN. Northland Securities cut shares of Amarin from an "outperform" rating to a "market perform" rating in a report on Wednesday, May 4th. SVB Leerink lowered shares of Amarin from an "outperform" rating to a "market perform" rating and reduced their price target for the stock from $10.00 to $3.00 in a research report on Thursday, May 5th. JPMorgan Chase & Co. lowered shares of Amarin from a "neutral" rating to an "underweight" rating in a research report on Friday, May 6th. HC Wainwright downgraded shares of Amarin from a "buy" rating to a "neutral" rating and dropped their price target for the company from $10.00 to $3.00 in a research note on Thursday, May 5th. Finally, StockNews.com raised shares of Amarin from a "sell" rating to a "hold" rating in a research note on Wednesday, July 27th. Two equities research analysts have rated the stock with a sell rating, four have issued a hold rating and one has issued a buy rating to the company's stock. According to data from MarketBeat, Amarin presently has an average rating of "Hold" and an average target price of $2.50.
IF it works for cognitive performance can we give it to EUNUCHA ( formerly AMRN ) Execs ?
YOu may be right looks like punk is in the chair and clippers have been started ...lol
Or in other words BUSINESS COMPETENCE AND ACUMEN both items sorely missing at EUNUCHA
Blockbuster drug for the world's major killer and they cant make a go of it ...tragically hilarious
EUNUCHA ( formerly AMRN) couldn't sell water in the desert
Eunucha punk pouring rogaine on that hair
Jroon you have hit the nail on the head EXACTLY !! The only event I see moving things would be healthnet case in 2023 otherwise we can just have fun at EUNUCHA'S expense ...lol
MAybe Eunucha finally realizes that calling EPA fish oil is a no starter. Now calling a compound "MD-2119" well that makes Docs think that this is one of a 1000 compounds that were created and researched to get the absolute best one - it was like mixing ammonia alcohol and water then calling it purple cleaner formula 409 - its all about marketing and EUnucha couldn't sell water in the desert .
BUt you can't remove generics and iNsurance companies will simply substitute generic EPA bid
Eunucha punk got rogaine yesterday ....lol
Well FFS I have to say you finally stated when you were buying and at what cost and I congratulate you on your call .
So has BP picked up on the fact that EPA reduces events by 25% due to anticoagulation and is now pushing their anticoagulants ?
I am seeing a very strong push to use eliquis and xarelto etc as a prevention not only in CAD but also PAD and CVA.
MOre pressure on Eunucha who is unable to capitalize on their own research. Pradaxa was the first NOAC no one even uses it now. They were totally replaced by BP's eliquis and Xarelto .
AF was correct, Eunucha trying to play with the big dogs and they are just lifting their legs.
I'm not so certain BBI - A study using EPA injectable in acute infarct or at cath could easily be performed in 6mos to a year.
What is fascinating is the question
IS Vascepa's benefit also from reduction of coagulation and not from reduction of inflammation or inflammatory cascades or is it both or is coagulation somehow linked to inflammatory cascades ?
and they will do the exact same with the once a day formulation they will just say you need to take generic twice a day
Well you are correct Eunuchas leg may not work and it is missing the wheels
Exactly this is an investment site - we are here to make money whether its long or shorting. CONGRATS to anyone who is making money . FOr those of you who think the only purpose of this site is to serve as a cheerleader for a third rate flunky pharmaceutical firm you have missed the point entirely.
I would bet on Eunucha's management buffoonery as being the most sure and consistent variable with this stock .... GO EUNUCHA !!
No I am still on the sidelines . I actually think the EUNUCHA Punk is stuck in a trading range until some event breaks them loose. BUt congrats if you can make money trading in that range.
The only event I see on the horizon that will do that is the Healthnet case everything else is wishful thinking and the grasping at straws of a drowning company, but as the saying goes "Its not over until the fat EUNUCH sings "
Is EUNUCHA Bankrupt yet ?
Great call Iwanderer
A lot of the new research on preventing CAD is to prevent thrombus formation. You are going to see all the major anticoagulants pushed for this - another nail in the coffin of EUNUCHA !
Capt Beer Im not certain of the speed of reduction of inflammation but my guess is the research will be directed at reducing infarct size at time of occurrence and being given during stenting etc .
EUNUCHA could take lessons in how to subtly destroy your competition as they were destroyed in this article. THis article basically introduces doubt into any patient whose doctor prescribes VASCEPA leaving them thinking WOW this may not even work and does my doctor know what they are doing
And you seriously actually believe that matter to insurers ?
and whats to stop them from substituting BID generic vascepa ?
ILT I would warn you about miracle EUNUCHA SAVIORS - be it Marjac, law suits, BB, Denner, new formulations etc etc - these are simply hopes and its great to have them but in investing, wait for proof - like Buffet says - find companies that are making money - then buy them
TTE you do of course realize that the CHURCH of EUNUCHA may excommunicate you for such heresy ....
There are rumors that AMRN is having SUPER SECRET MEETINGS and is fixing all of this
CONGRATS IWANDERER ... you called it well !! EUNUCHA doesn't turn skin head until it hits double digits ...lol